BridgeMD
New treatment option for in Relation to Sickle Cell Disease
Official title Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"
ClinicalTrials.gov ID: NCT06735625
What this study is testing
What is Measurement of AHSP concentration?
Measurement of AHSP concentration is an investigational medicine, being studied as a potential treatment for in relation to sickle cell disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Evaluation of AHSP concentration in total blood as a biomarker in adult and pediatric sickle cell patients
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 and older
You may be able to join if
- for Sickle Cell Patients
- Adults: \> 15 years and 6 months
- Pediatrics: ≥ 3 years and ≤ 15 years and 6 months
- Known SS or Sβ0 phenotypes for Control Patients. 1 -Adults: \> 15 years and 6 months /Pediatrics: ≥ 3 years and ≤ 15 years and 6 months 2-Absence of...
You likely can't join if
- Hemoglobin disorder other than sickle cell disease (Criteria for Sickle Cell Patients)
- Hemoglobinopathies other than sickle cell disease (Criteria for Control Patients)
- Transfusion less than 3 months ago
- Chronic active viral disease: hepatitis B, C, HIV
- Current infections or known inflammatory pathologies
- Known hyper or hypothyroidism or subject treated with levothyroxine
See the full eligibility criteria
- for Sickle Cell Patients
- Adults: \> 15 years and 6 months
- Pediatrics: ≥ 3 years and ≤ 15 years and 6 months
- Known SS or Sβ0 phenotypes for Control Patients. 1 -Adults: \> 15 years and 6 months /Pediatrics: ≥ 3 years and ≤ 15 years and 6 months 2-Absence of Hemoglobinopathy 3-Follow-up for one of the following conditions...
- Hemoglobin disorder other than sickle cell disease (Criteria for Sickle Cell Patients)
- Hemoglobinopathies other than sickle cell disease (Criteria for Control Patients)
- Transfusion less than 3 months ago
- Chronic active viral disease: hepatitis B, C, HIV
- Current infections or known inflammatory pathologies
- Known hyper or hypothyroidism or subject treated with levothyroxine
- Active tumor pathology or remission for less than 5 years
- Oral corticosteroid therapy in progress
- Participation in treatment biomedical research
- Opposition to participation in research by the patient if he is an adult, or by one of the two parents if the patient is a minor.
- Non-affiliation to a social security system
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Denis, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Denis, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.